» Articles » PMID: 33732447

Inter-site and Interpersonal Diversity of Salivary and Tongue Microbiomes, and the Effect of Oral Care Tablets

Overview
Journal F1000Res
Date 2021 Apr 20
PMID 33732447
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Oral microbiota has been linked to both health and diseases. Specifically, tongue-coating microbiota has been implicated in aspiration pneumonia and halitosis. Approaches altering one's oral microbiota have the potential to improve oral health and prevent diseases. Here, we designed a study that allows simultaneous monitoring of the salivary and tongue microbiomes during an intervention on the oral microbiota. We applied this study design to evaluate the effect of single-day use of oral care tablets on the oral microbiome of 10 healthy individuals. Tablets with or without actinidin, a protease that reduces biofilm formation , were tested. Alpha diversity of the tongue microbiome was significantly lower than that of the salivary microbiome, using both the number of observed amplicon sequence variants (254 ± 53 in saliva and 175 ± 37 in tongue; = 8.9e-7, Kruskal-Wallis test) and Shannon index (6.0 ± 0.4 in saliva and 5.4 ± 0.3 in tongue; = 2.0e-7, Kruskal-Wallis test). , , subsp , , , , and were the core operational taxonomic units (OTUs) common to both sites. The salivary and tongue microbiomes of one individual tended to be more similar to one another than to those of other individuals. The tablets did not affect the alpha or beta diversity of the oral microbiome, nor the abundance of specific bacterial species. While the salivary and tongue microbiomes differed significantly in terms of bacterial composition, they showed inter- rather than intra-individual diversity. A one-day usage of oral care tablets did not alter the salivary or tongue microbiomes of healthy adults. Whether the use of oral tablets for a longer period on healthy people or people with greater tongue coating accumulation shifts their oral microbiome needs to be investigated.

Citing Articles

therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.

Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K Oncoimmunology. 2022; 11(1):2081010.

PMID: 35655708 PMC: 9154751. DOI: 10.1080/2162402X.2022.2081010.


Oral care tablet containing kiwifruit powder affects tongue coating microbiome.

Fukui M, Asakuma H, Horiuchi H, Takii H, Yoshioka M, Hinode D Clin Exp Dent Res. 2022; 8(3):721-728.

PMID: 35579104 PMC: 9209808. DOI: 10.1002/cre2.591.


Exploring the Connection between and Neurodegenerative Diseases: A Pilot Quantitative Study on the Bacterium Abundance in Oral Cavity and the Amount of Antibodies in Serum.

Franciotti R, Pignatelli P, Carrarini C, Romei F, Mastrippolito M, Gentile A Biomolecules. 2021; 11(6).

PMID: 34204019 PMC: 8229521. DOI: 10.3390/biom11060845.


Inter-site and interpersonal diversity of salivary and tongue microbiomes, and the effect of oral care tablets.

Maruyama H, Masago A, Nambu T, Mashimo C, Takahashi K, Okinaga T F1000Res. 2021; 9:1477.

PMID: 33732447 PMC: 7921892. DOI: 10.12688/f1000research.27502.2.

References
1.
Nohno K, Yamaga T, Kaneko N, Miyazaki H . Tablets containing a cysteine protease, actinidine, reduce oral malodor: a crossover study. J Breath Res. 2012; 6(1):017107. DOI: 10.1088/1752-7155/6/1/017107. View

2.
Menon R, Gomez A, Brandt B, Leung Y, Gopinath D, Watt R . Long-term impact of oral surgery with or without amoxicillin on the oral microbiome-A prospective cohort study. Sci Rep. 2019; 9(1):18761. PMC: 6904678. DOI: 10.1038/s41598-019-55056-3. View

3.
Greenwood D, Afacan B, Emingil G, Bostanci N, Belibasakis G . Salivary Microbiome Shifts in Response to Periodontal Treatment Outcome. Proteomics Clin Appl. 2020; 14(3):e2000011. DOI: 10.1002/prca.202000011. View

4.
Hall M, Singh N, Ng K, Lam D, Goldberg M, Tenenbaum H . Inter-personal diversity and temporal dynamics of dental, tongue, and salivary microbiota in the healthy oral cavity. NPJ Biofilms Microbiomes. 2017; 3:2. PMC: 5445578. DOI: 10.1038/s41522-016-0011-0. View

5.
Tanabe S, Grenier D . Characterization of volatile sulfur compound production by Solobacterium moorei. Arch Oral Biol. 2012; 57(12):1639-43. DOI: 10.1016/j.archoralbio.2012.09.011. View